The following interview with Dr Eric Jonasch, medical oncologist from MD Anderson Cancer Centre in Texas, USA, discusses various clinical trials of immunotherapy for the treatment of rare subtypes of kidney cancer, such as papillary and chromophobe renal cell carcinoma (RCC). Dr Jonasch was interviewed at the 2018 American Society of Clinical Oncology (ASCO) annual meeting in Chicago this week.

Watch the interview on Practice Update here